Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 165 participants.

Also called NCT07604922

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose basic science
Phase
Not applicable
Enrolled
  • 165 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07604922
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07604922. Non-randomized; no masking; primary purpose basic science. Start 2026-09-17 (actual); primary completion 2028-03-15 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Acronym
STIMULUS-CKD
Condition
Hypertension (HTN)
Condition
Type 2 Diabetes Mellitus (T2DM)
Intervention (Device)
HEMI device
Intervention (Device)
SPG-NINOX device
Lead sponsor
Institut National de la Santé Et de la Recherche Médicale, France (class: other government)
Collaborator
University of Turku (class: other)
Collaborator
Imec (class: industry)

Record details

Record id
cardio:ct-nct07604922
Content hash
9dd73943e48390b3831d710e740ad0dab662cbb86d06308f237ce2d935fe47fb